Cargando…

c-Met and PD-L1 on Circulating Exosomes as Diagnostic and Prognostic Markers for Pancreatic Cancer

Exosomes are membrane vesicles which offer potential as blood derived biomarkers for malign tumors in clinical practice. Pancreatic cancer is counted among cancer diseases with the highest mortality. The present work seeks to assess whether pancreatic carcinomas release exosomes which express c-Met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lux, Alexander, Kahlert, Christoph, Grützmann, Robert, Pilarsky, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651266/ https://www.ncbi.nlm.nih.gov/pubmed/31284422 http://dx.doi.org/10.3390/ijms20133305

Ejemplares similares

The Role of Exosomes in Pancreatic Cancer
por: Lan, Bin, et al.
Publicado: (2019)

Serum Tumor Markers in Pancreatic Cancer—Recent Discoveries
por: Rückert, Felix, et al.
Publicado: (2010)

Molecular Pathogenesis of Pancreatic Neuroendocrine Tumors
por: Ehehalt, Florian, et al.
Publicado: (2010)

Prognostic impact of a compartment-specific angiogenic marker profile in patients with pancreatic cancer
por: Kahlert, Christoph, et al.
Publicado: (2014)

Identification of Prognostic Biomarkers by Combined mRNA and miRNA Expression Microarray Analysis in Pancreatic Cancer
por: Liu, Bin, et al.
Publicado: (2018)

Chemoresistance in Pancreatic Cancer
por: Zeng, Siyuan, et al.
Publicado: (2019)

The Role of Apoptosis in the Pathology of Pancreatic Cancer
por: Samm, Nicole, et al.
Publicado: (2010)

Role of circulating exosomal biomarkers and their diagnostic accuracy in pancreatic cancer
por: Sha, Menazir, et al.
Publicado: (2022)

Plasma extracellular vesicle messenger RNA profiling identifies prognostic EV signature for non-invasive risk stratification for survival prediction of patients with pancreatic ductal adenocarcinoma
por: Han, Yi, et al.
Publicado: (2023)

Current Clinical Strategies of Pancreatic Cancer Treatment and Open Molecular Questions
por: Brunner, Maximilian, et al.
Publicado: (2019)

Combinational blockade of MET and PD-L1 improves pancreatic cancer immunotherapeutic efficacy
por: Li, Enliang, et al.
Publicado: (2021)

Precursor Lesions for Sporadic Pancreatic Cancer: PanIN, IPMN, and MCN
por: Distler, M., et al.
Publicado: (2014)

A Circulating Exosome RNA Signature Is a Potential Diagnostic Marker for Pancreatic Cancer, a Systematic Study
por: Wu, Yixing, et al.
Publicado: (2021)

Neoadjuvant Therapy in Patients with Pancreatic Cancer: A Disappointing Therapeutic Approach?
por: Zimmermann, Carolin, et al.
Publicado: (2011)

Tracking the evolution of circulating exosomal-PD-L1 to monitor melanoma patients
por: Cordonnier, Marine, et al.
Publicado: (2020)

Silenced ZNF154 Is Associated with Longer Survival in Resectable Pancreatic Cancer
por: Wiesmueller, Felix, et al.
Publicado: (2019)

Postoperative course and prognostic value of circulating angiogenic cytokines after pancreatic cancer resection
por: Yang, Cui, et al.
Publicado: (2017)

Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenocarcinoma
por: Daunke, Tina, et al.
Publicado: (2023)

Evaluation of survival in patients after pancreatic head resection for ductal adenocarcinoma
por: Distler, Marius, et al.
Publicado: (2013)

Feedback within the Inter-Cellular Communication and Tumorigenesis in Carcinomas
por: Rückert, Felix, et al.
Publicado: (2012)

Evaluation of circulating PD-1 and PD-L1 as diagnostic biomarkers in dogs with tumors
por: Song, Doo-Won, et al.
Publicado: (2021)

Simultaneous gene silencing of KRAS and anti-apoptotic genes as a multitarget therapy
por: Werner, Kristin, et al.
Publicado: (2015)

It Takes Two to Tango: Potential Prognostic Impact of Circulating TGF-Beta and PD-L1 in Pancreatic Cancer
por: Garajová, Ingrid, et al.
Publicado: (2022)

Simultaneous gene silencing of Bcl-2, XIAP and Survivin re-sensitizes pancreatic cancer cells towards apoptosis
por: Rückert, Felix, et al.
Publicado: (2010)

Progress on diagnostic and prognostic markers of pancreatic cancer
por: YANG, HONG, et al.
Publicado: (2023)

The G Protein-Coupled Receptor RAI3 Is an Independent Prognostic Factor for Pancreatic Cancer Survival and Regulates Proliferation via STAT3 Phosphorylation
por: Jahny, Elisabeth, et al.
Publicado: (2017)

CRISPR/Cas9-Mediated Knock-Out of Kras(G12D) Mutated Pancreatic Cancer Cell Lines
por: Lentsch, Eva, et al.
Publicado: (2019)

Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTLA in patients with pancreatic adenocarcinoma
por: Bian, Benjamin, et al.
Publicado: (2019)

Correlation of MET and PD-L1 Expression in Malignant Melanoma
por: Song, Kyu Young, et al.
Publicado: (2020)

Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
por: Shin, Kabsoo, et al.
Publicado: (2023)

Screening of Exosome-Derived Proteins and Their Potential as Biomarkers in Diagnostic and Prognostic for Pancreatic Cancer
por: Marin, Anelis Maria, et al.
Publicado: (2023)

Circulating pancreatic cancer exosomal RNAs for detection of pancreatic cancer
por: Kitagawa, Tatsuya, et al.
Publicado: (2018)

An m5C methylation regulator-associated signature predicts prognosis and therapy response in pancreatic cancer
por: Yun, Duo, et al.
Publicado: (2022)

Circulating Monocytes Serve as Novel Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma Patients
por: Hansen, Frederik J., et al.
Publicado: (2023)

Impact of CRISPR/Cas9-Mediated CD73 Knockout in Pancreatic Cancer
por: Zhang, Jinping, et al.
Publicado: (2023)

Diagnostic technologies for circulating tumour cells and exosomes
por: Shao, Huilin, et al.
Publicado: (2016)

Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma
por: Rückert, F, et al.
Publicado: (2008)

ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma
por: Grützmann, R, et al.
Publicado: (2004)

Advances in circulating microRNAs as diagnostic and prognostic markers for ovarian cancer
por: Zheng, Hong, et al.
Publicado: (2013)

Clinical significance of serum-derived exosomal PD-L1 expression in patients with advanced pancreatic cancer
por: Park, Se Jun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ph60736a80nrjeu4afms1aijbg